logo
Taking a mental health leave from work is an option most people don't know about

Taking a mental health leave from work is an option most people don't know about

The Hill17-04-2025
NEW YORK (AP) — Her first panic attack came at a company-wide meeting, right before her scheduled presentation. Carolina Lasso had given many similar talks about her marketing team's accomplishments. When her name was called this time, she couldn't speak.
'I felt a knot in my throat,' Lasso said. 'My head, it felt like it was inside a bubble. I couldn't hear, I couldn't see, and it felt like an eternity. It was just a few seconds, but it was so profound, and in a way earth-shattering to me.'
Lasso was struggling after a cross-country move followed by a divorce. Her boss suggested a mental health leave, a possibility she didn't know existed. She worried whether taking time off would affect how her team viewed her or cost her a future promotion, but in the end she did.
'I'm thankful for that opportunity to take the time to heal,' Lasso, 43, said. 'Many people feel guilty when they take a leave of absence when it's mental health-related. … There is some extra weight that we carry on our shoulders, as if it had been our fault.'
Despite a fear of repercussions, more adults are recognizing that stepping back from work to deal with emotional burdens or psychological conditions that get in the way of their lives is a necessary choice, one that a growing number of employers recognize.
ComPsych Corp., a provider of employee mental health programs and absence management services, encourages its business clients to make the well-being of workers a priority before individuals get to a breaking point while also having processes in place for those who require leaves of absence.
'Since the start of the COVID-19 pandemic, collectively we've just been in this constant state of turmoil,' Jennifer Birdsall, the senior clinical director at ComPysch, said. 'We just have had this barrage of change and uncertainty.'
Depression, anxiety and adjustment disorder, which involves excessive reactions to stress, were the top three diagnoses of employees who took mental health leaves in the past two years among clients of Alight, a Chicago-based technology company which administers leaves and benefits for large employers.
Structuring a leave
A mental health leave can last weeks or months. In some cases, workers get approval to work a reduced schedule or to take short periods of time off when needed, using an approach called 'intermittent leave.'
At most U.S. organizations with 50 or more employees, people can request leaves through the Family and Medical Leave Act. The federal law entitles workers with serious health conditions to paid or unpaid leaves of up to 12 weeks, depending on state and local laws.
Some employers require people to use sick days or accumulated vacation days to continue receiving a paycheck while out. For longer leaves, workers can access short-term disability plans, if their employer offers one.
Lasso's leave lasted six months, and included therapy and travel to India for additional treatment. She returned to her job but decided after a year to leave for good. She later launched a business to train people on fostering a more humane work culture.
A mental health leave is 'not only OK, but it can really unlock new possibilities once we have the time to do the work — therapy, medication, whatever it is — and have enough distance from work to be able to reconnect with ourselves,' Lasso said.
Talking openly about struggles
A social stigma around mental health challenges causes many people to avoid seeking treatment or requesting a leave of absence. Newton Cheng, director of health and performance at Google, hopes to change that by sharing his own struggles.
His first self-disclosure happened during the pandemic, when a senior manager invited employees at a meeting to share how they were doing. When it was his turn, Cheng started crying.
He explained he was struggling to live up to his expectations of himself as a father and didn't know how to turn things around.
'It was just totally horrifying to me because, one, I had just cried in front of my coworkers and I was definitely taught as a professional — and as a man — you do not do that,' Cheng recalled. 'And then two, I had never really articulated and said out loud those words. I hadn't even allowed myself to think that. But now they're out there and I had to face them.'
Colleagues responded by relaying their own struggles, but Cheng's difficulties continued. By February 2021, he couldn't get out of bed because he felt paralyzed by dread, he said. A therapist said he was showing symptoms of major depression and anxiety.
'I just realized, 'I'm struggling a lot and this goes pretty deep. I don't think I can keep just putting duct tape on this. I probably need to take some leave,'' Cheng recalled.
Hoping his decision would benefit others, he announced to 200 people at a conference that he planned to take mental health leave. Instead of derailing the gathering as he feared, his honesty inspired fellow conference attendees to open up.
'It was like a fireworks show,' Cheng said. 'They're like, 'Wow, I can't believe he did that.' Then they forgot about me. But the tone was set. It was like 'Oh, this is what we're doing. Let me talk about what's going on with me, too.''
Take the time you need
While balancing classes and a full-time job during her last year of college, Rosalie Mae began struggling to get out of bed and crying uncontrollably. Yet she felt like she had 'to keep it together' to avoid burdening her colleagues at the University of Utah bookstore, where Mae worked as an accounting clerk.
Then she found herself calling a suicide hotline. 'Once it reached that point, I knew, especially at the urging of my husband, we need to do something more,' Mae, 24, said.
In her case, that meant taking a five-week work leave to put her own health and well-being first. She recommends the same for others who find themselves in a similar position.
'Taking a mental health leave is not necessarily a cure-all, but it is important to give yourself a break and allow yourself to regroup, make a plan of how to proceed and take the steps to work towards feeling better,' Mae said.
Telling managers and colleagues
Before broaching the subject of a mental health leave with a manager, consider the workplace culture and the strength of your professional relationships, Cheng said. He recalls saying, 'For my health and well-being, and the sake of my family and what's best for the business, the least risky thing for me to do is to go on leave soon.'
Individuals who suspect an unsympathetic reception can simply say, 'I need to go on medical leave. I need time to recover,' he advised.
There's also no legal or ethical requirement to tell everyone you work with the nature of your leave.
'Your coworkers don't need to know why,' said Seth Turner, co-founder of AbsenceSoft, a leave and accommodation management solutions provider. 'They just need to know, 'I'm going to be here at this time, and I'm going to be gone at this time, and I'll be back.''
___
Have you overcome an obstacle or made a profound change in your work? Send your questions and story ideas to cbussewitz@ap.org. Follow AP's Be Well coverage, focusing on wellness, fitness, diet and mental health at https://apnews.com/hub/be-well.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Watch out Fitbit and Apple Watch, Amazon has entered the chat
Watch out Fitbit and Apple Watch, Amazon has entered the chat

Miami Herald

time2 hours ago

  • Miami Herald

Watch out Fitbit and Apple Watch, Amazon has entered the chat

You've seen them on wrists and fingers everywhere - at the gym, in the office, on the subway. Smartwatches and fitness trackers have become the quiet uniform of modern life. For many, they track steps. For others, they serve as sleep monitors, heart rate checkers, or reminders to stand every hour. But despite their popularity, most of these devices do the exact same thing. And frankly, they've started to Whether it's an Apple Watch, a Fitbit, or a Garmin, the core experience hasn't evolved much over the past few years. Related: Amazon's latest products go after a new type of customer Sure, there are better sensors and more polished apps. But the function is nearly identical: collecting health data and feeding it back to you in yet another dashboard you'll probably stop checking. What wearables haven't done, at least not well, is make your life easier in the moment. That may be why one small company decided to build something different. And now, a major tech giant just announced plans to acquire that company, marking a bold return to a space it once gave up on. That company is Amazon. And the startup it's buying is called Bee. Amazon confirmed this week that it will acquire Bee, a San Francisco-based startup behind a $49.99 AI-powered wristband. Bee's device is sleek and screenless, but packed with purpose. It uses onboard microphones and generative AI to listen to daily conversations - like work calls, casual chats, or even errands shouted across the room - and then distills that information into summaries, reminders, or to-do lists. Think: a wearable that doesn't just track your health, it helps you manage your life. In a LinkedIn post, Bee CEO Maria de Lourdes Zollo described the vision as "truly personal, agentic AI." Related: Apple Watch, Fitbit rival stuns with bold message "We imagined a world where your life is understood and enhanced by technology that learns with you," she wrote. Amazon spokesperson Alexandra Miller confirmed the acquisition but didn't share financial details. The move comes as Amazon expands its AI ambitions with projects like the shopping assistant Rufus and a revamped Alexa voice assistant. It also marks a second swing at wearables after Amazon discontinued its Halo fitness tracker in 2023. This time, though, the angle isn't frictionless productivity. Apple and Fitbit have long defined what wearables are supposed to do. Track your steps. Nudge you to stand. Alert you when your heart rate spikes. But those features haven't changed much in the past five years, and they haven't solved a bigger problem: information overload. Bee offers something different. Its core value isn't movement tracking or health metrics; it's saving time and promoting mental clarity. Instead of keeping you glued to your screen, it wants to take tasks off your mind. That kind of AI-assisted memory could appeal to students, professionals, parents, and anyone juggling a busy life. And because it's currently priced at just $49.99, it lowers the barrier to entry significantly. By comparison, the Apple Watch SE starts at $249. Fitbit's latest models range from $100 to $300. This isn't just another gadget - it's a rethink of what a wearable should be. With Amazon backing it, Bee now has the infrastructure to scale, and the resources to improve. If Apple, Google, WHOOP, and Meta weren't already watching, they are now. And with OpenAI, Humane, and others chasing similar hardware ambitions, the AI-on-your-body race is officially on. Related: Amazon's Alexa AI upgrade is even worse than expected The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.

Covid-19 drug company liquidates assets in Chapter 11 bankruptcy
Covid-19 drug company liquidates assets in Chapter 11 bankruptcy

Miami Herald

time3 hours ago

  • Miami Herald

Covid-19 drug company liquidates assets in Chapter 11 bankruptcy

When the Covid-19 public health crisis began in the U.S. with the first confirmed case of the 2019 Novel Coronavirus in Washington state on Jan. 20, 2020, the terrifying pandemic was underway, and the Centers for Disease Control and Prevention would report its first confirmed death from the virus on Feb. 29. By March 3, 2020, CDC reported 60 confirmed cases in 12 states. On March 13, the first Trump administration declared a national emergency, and states started implementing shutdowns on March 15, according to the CDC's timeline of Covid-19 events. Don't miss the move: Subscribe to TheStreet's free daily newsletter Biotechnology firms Pfizer-BioTech and Moderna Therapeutics began developing Covid-19 vaccines in March 2020, and by November 2020, each company's Covid-19 vaccine would be found 95% effective in clinical trials. Related: CVS rival pharmacy chain files for Chapter 11 bankruptcy Another biotech firm, Regeneron, in November received approval of an antibody treatment to significantly reduce virus levels within days. In December 2020, Covid-19 vaccinations began, and by Dec. 24, 1 million people had been vaccinated in the U.S. CDC said that by June 1, 2022, the U.S. reported over 84 million Covid-19 infections and over 1 million deaths. About a year later, Pfizer reported on its website that on May 5, 2023, the World Health Organization declared an end to the Covid-19 public health emergency, while the U.S. Department of Health & Human Services did the same on May 11, 2023. The healthcare industry's response to the Covid-19 pandemic was so effective that beginning on May 1, 2024, hospitals were no longer required to report Covid-19 hospital admissions, hospital capacity, or hospital occupancy data to the U.S. Department of Health & Human Services through the Centers for Disease Control and Prevention's National Healthcare Safety Network, according to the CDC website. The end of the crisis also ended the need for massive amounts of Covid-19 drugs. With the Covid-19 pandemic subsiding, companies that stepped forward to develop vaccines, drugs, and treatments during the crisis are now facing declining demand for their services to develop Covid-19 products. With no dire need for Covid-19 products, some drug companies have been forced to downsize or even shut down operations because of a lack of business opportunities. Essential drug manufacturer Aluchua Government Services Inc., which developed Covid-19 therapy drugs under U.S. government contracts, has filed for Chapter 11 bankruptcy with plans to wind down operations and sell its assets. Related: Giant healthcare company files Chapter 11 bankruptcy seeking sale The Aluchua, Fla.-based pharmaceutical company filed its petition in the U.S Bankruptcy Court for the District of Delaware, listing $50 million in assets and $100 million to $500 million in liabilities. The debtor's largest creditors include United States International Development Finance Corp., owed $246 million; Defense Contract Management Agency, owed $11.95 million; and Sigma-Aldrich Inc. $1.33 million. Aluchua was founded in 1999 to develop new drugs and to increase efficacy of existing ones. In 2013, it was awarded a greenfield contract with the U.S. Department of Defense, and in February 2020, it was awarded a contract to develop an advanced monoclonal antibody therapy against Covid-19 infection. The Covid-19 drug was one of several that the debtor partnered with the U.S. government to develop and produce drugs, vaccines, and treatments. The debtor needed to file for Chapter 11 protection after demand for its services began to decline in late 2023 and certain government contracts were wound down or scaled back, according to Aluchua's Chief Restructuring Officer Janet R. Naifeh of FTI Consulting Inc. Aluchua's efforts to replace its government business with commercial contracts failed, which forced it to scale down production and lay off 125 employees from January through April 2025. It reduced its staff by another 67 employees on June 20 and July 1, which, combined with the earlier layoffs, amounted to termination of 80% of its workforce. The company employed 13 full-time and three temporary workers as of the petition date. The company marketed itself for sale beginning in February 2025, but was unable to complete a transaction and decided its only viable option was to file for Chapter 11 bankruptcy, wind down its business, and sell its assets. Related: Iconic retail chain closing its remaining stores in bankruptcy The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.

Summer Covid cases are rising across the U.S. — Is it time for a vaccine?
Summer Covid cases are rising across the U.S. — Is it time for a vaccine?

Yahoo

time3 hours ago

  • Yahoo

Summer Covid cases are rising across the U.S. — Is it time for a vaccine?

As Covid cases begin to rise this summer, many may be wondering: What are my risks, and is it time to get another vaccine? As of July 15, Covid cases were growing or likely growing in 27 states including Texas, Illinois, Kentucky, Virginia and Ohio, according to the Centers for Disease Control and Prevention. Rates of positive Covid tests have also been increasing in recent weeks, the CDC says, specifically in the southern region of the country. N.B.1.8.1 is the current dominant variant in the United States, accounting for 43% of all new Covid cases, according to the CDC. It's an offshoot of the XVD.1.5.1 strain, a descendant of the omicron variant. N.B.1.8.1 was responsible for a surge in hospitalizations in China earlier this year. It's been nicknamed 'razor blade throat,' as there have been anecdotal reports of some people getting painful sore throats, said Dr. William Schaffner, an infectious disease expert at Vanderbilt University Medical Center in Nashville, Tennessee. Schaffner noted, however, that sore throats have been a common symptom of Covid since it first began spreading. 'I doubt the clinical spectrum of Covid has changed substantially,' Schaffner said. Do I need a Covid booster? When will the new vaccines be available? The uptick in cases comes as many Americans have likely gone a year or longer without a Covid shot. In May, the Food and Drug Administration asked drugmakers to update their Covid vaccines to target the LP.8.1 strain, a descendent of JN.1, which began spreading widely in 2023 and is another offshoot of omicron. LP.8.1 currently accounts for 31% of all new cases, per the CDC. The new shots won't be available until the fall, and are expected to be approved only for adults 65 and up and kids and adults with at least one medical condition that puts them at risk of severe illness. Healthy kids and adults who want a shot may have to find an older version or pay out of pocket. A single dose can cost as much as $140. Experts say, however, that population immunity — whether from vaccination, prior infection or both — may shield much of the public for now. 'While we don't have a lot of high level of immunity in the population right now, because it's been so long, we may have enough low level immunity to just make it a little bit harder for that virus to transmit easily from person to person,' said Andy Pekosz, an infectious disease researcher at Johns Hopkins University. Indeed, weekly hospitalization rates have remained low, suggesting that the new variant may not be leading to severe illness. The number of cases are still drastically lower than those this time last year, when the test positivity rate peaked in August at 17.9%. The 2025 season has yet to scrape 5%. Pekosz said it isn't unusual for cases to rise during the summer time, when people are likely to crowd indoors to escape the heat. However, he believes that if there is a summer surge of cases, it will be a small one. 'The variants have been around for a while and haven't caused any major surges up until date,' Pekosz said. 'So again, I'm hopeful that if we see a surge, it'll be a low level surge compared to previous years.' Dr. Ofer Levy, director of the precision vaccines program at Boston Children's Hospital, who has advised the FDA, said people who are at high risk of severe illness still may want to consider getting a Covid shot, if they can find one. High risk groups include: Older adults People with weakened immune systems Pregnant women Those with underlying health conditions, such as asthma and heart disease Getting a shot is especially important, Levy said, for those who haven't had one in over a year and whose immunity has likely waned. 'If you're in a high risk group and you're in a state where cases are rising, you may want to just get the first available appointment and get a shot to protect yourself,' he said. People at high risk can then consider getting an additional Covid shot when the updated vaccines are distributed in the fall, he said. Covid has two waves a year Schaffner, of Vanderbilt, said people in the high risk groups may also want to consider wearing a mask during indoor activities, such as the movies. Healthy adults and children may be able to wait longer before getting another shot, Levy added. 'If you're in a lower risk group, that's where things get fuzzy,' he said. 'I mean if you want a vaccine and your health care provider concurs and you can get it.' Dr. Michael Phillips, an infectious disease doctor at NYU Langone, said that he sees mostly immunocompromised and older adults test positive for the virus. For those who haven't gotten a Covid shot in years, Phillips said he doesn't think they should worry just yet. 'If you're younger, otherwise healthy, I think you're OK,' Phillips said. 'If you have underlying pulmonary disease, you know, if you're an older age group, now that's a time when you should be really talking to a doctor and saying, 'Gosh, should I be getting a booster for Covid?'' He said that the amount of positive Covid tests NYU Langone has seen has decreased 40% since February. Fatima Amaeka, a senior analyst at the Center for Outbreak Response Innovation at Johns Hopkins, said she expects the current wave to peak around September. Schaffner said to expect another wave in the late fall and winter. '[Covid] has two increases each year,' he said. 'Everyone is familiar with the winter increase that goes along with flu and RSV.' This article was originally published on Solve the daily Crossword

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store